MedPath

University of Nottingham

🇬🇧United Kingdom
Ownership
-
Established
1881-01-01
Employees
-
Market Cap
-
Website
https://www.nottingham.ac.uk/

Skeletal Muscle Wasting and Insulin Resistance Following Surgical Stress

Completed
Conditions
Insulin Resistance
Interventions
Procedure: Major abdominal surgery
First Posted Date
2010-06-02
Last Posted Date
2015-06-09
Lead Sponsor
University of Nottingham
Target Recruit Count
15
Registration Number
NCT01134809
Locations
🇬🇧

University Hospitals Nottingham Queen's Medical Centre, Nottingham, United Kingdom

The Effect of Crystalloids and Colloids on Visceral Blood Flow

Phase 1
Completed
Conditions
Fluid Overload
Water Electrolyte Imbalance
Acid Base Imbalance
Interventions
Drug: Crystalloid
Drug: Colloid
First Posted Date
2010-03-16
Last Posted Date
2011-06-01
Lead Sponsor
University of Nottingham
Target Recruit Count
25
Registration Number
NCT01087853
Locations
🇬🇧

Brain and Body MRI Centre, University of Nottingham, Nottingham, Nottinghamshire, United Kingdom

Effects of Aromatherapy on Childbirth

Phase 2
Conditions
Natural Childbirth
Labor Pain
Parturition
Interventions
Other: None essential oil
Other: Aromatherapy oil
First Posted Date
2010-01-18
Last Posted Date
2013-01-16
Lead Sponsor
University of Nottingham
Target Recruit Count
90
Registration Number
NCT01051726
Locations
🇬🇧

Kings Mill Hospital, Nottingham, United Kingdom

The Metabolic Effects of a High Fructose Versus a High Glucose Diet in Overweight Men

Not Applicable
Completed
Conditions
Cardiovascular Status
Hepatic Fatty Acid Metabolism
Systemic Insulin Resistance
Oxidative Stress
Interventions
Dietary Supplement: high sugar diet
First Posted Date
2010-01-15
Last Posted Date
2012-07-04
Lead Sponsor
University of Nottingham
Target Recruit Count
32
Registration Number
NCT01050140
Locations
🇬🇧

School of Biomedical Sciences, University of Nottingham, Nottingham, Nottinghamshire, United Kingdom

Study Looking at Cardiovascular Effects of Exenatide, Its Blood Pressure Lowering Effect and Its Mechanisms

Not Applicable
Completed
Conditions
Type 2 Diabetes
Interventions
Drug: Saline
First Posted Date
2010-01-12
Last Posted Date
2018-03-06
Lead Sponsor
University of Nottingham
Target Recruit Count
8
Registration Number
NCT01046721
Locations
🇬🇧

David Greenfield Human Physiology Laboratories, Nottingham, Notts, United Kingdom

Maintenance of Muscle Mass in Older People: the Negative Impact of Statin Therapy

Completed
Conditions
Myopathy
First Posted Date
2010-01-12
Last Posted Date
2016-04-27
Lead Sponsor
University of Nottingham
Target Recruit Count
18
Registration Number
NCT01047163
Locations
🇬🇧

David Greenfield Physiology Laboratories, Nottingham, Nottinghamshire, United Kingdom

Virus Shedding and Environmental Deposition of a Novel Influenza Virus

Completed
Conditions
Novel (H1N1) Influenza
First Posted Date
2010-01-12
Last Posted Date
2012-09-27
Lead Sponsor
University of Nottingham
Target Recruit Count
105
Registration Number
NCT01046734
Locations
🇬🇧

Leicester University Hospitals NHS Trust, Leicester, United Kingdom

🇬🇧

Sheffield Teaching Hospitals NHS Trust, Sheffield, United Kingdom

🇬🇧

Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom

Trial of the Clinical and Cost Effectiveness of a Specialist Expert Mood Disorder Team for Refractory Unipolar Depressive Disorder

Not Applicable
Conditions
Chronic Unipolar Depressive Disorder
Interventions
Other: Specialist Mood Disorders Team
First Posted Date
2010-01-12
Last Posted Date
2015-12-09
Lead Sponsor
University of Nottingham
Target Recruit Count
219
Registration Number
NCT01047124
Locations
🇬🇧

Lincolnshire Partnership Trust, Lincoln, Lincolnshire, United Kingdom

🇬🇧

Derbyshire Mental Health NHS Trust, Derby, Derbyshire, United Kingdom

🇬🇧

Nottinghamshire Healthcare NHS Trust, Nottingham, Nottinghamshire, United Kingdom

The Efficacy of Nitric Oxide in Stroke (ENOS) Trial

Phase 3
Conditions
Stroke
Interventions
Drug: Pre-stroke antihypertensives
Drug: Transdermal glyceryl trinitrate patch
First Posted Date
2009-10-05
Last Posted Date
2012-07-24
Lead Sponsor
University of Nottingham
Target Recruit Count
3500
Registration Number
NCT00989716
Locations
🇬🇧

Nottingham University Hospitals NHS Trust (City Hospital), Nottingham, Nottinghamshire, United Kingdom

Doxycycline In Lymphangioleiomyomatosis (LAM)

Phase 4
Completed
Conditions
Lymphangioleiomyomatosis
Tuberous Sclerosis
Interventions
Drug: Placebo
First Posted Date
2009-10-05
Last Posted Date
2015-12-02
Lead Sponsor
University of Nottingham
Target Recruit Count
24
Registration Number
NCT00989742
Locations
🇬🇧

Nottingham University Hospitals, Nottingham, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath